Xiaoya Ma

Title: The Innovative Contributions of Xiaoya Ma

Introduction: Xiaoya Ma is a prominent inventor based in Laguna Hills, CA (US). He has made significant strides in the field of biomedical engineering, particularly in the development of anti-CD3 constructs. His work focuses on enhancing therapeutic strategies for cancer treatment.

Latest Patents: Xiaoya Ma holds a patent for "Anti-CD3 constructs and uses thereof." This patent describes tumor microenvironment acidity activated anti-CD3 constructs that bind to CD3, including anti-CD3 monoclonal and multispecific antibodies. The patent also covers nucleic acid molecules encoding an amino acid sequence of the anti-CD3, vectors comprising these nucleic acid molecules, and host cells containing the vectors. Additionally, it outlines methods for preparing the anti-CD3 construct, pharmaceutical compositions containing the construct, and methods for using the anti-CD3 construct or compositions.

Career Highlights: Xiaoya Ma is associated with Amberstone Biosciences, Inc., where he contributes to innovative research and development in the field of immunotherapy. His expertise in creating targeted therapies has positioned him as a valuable asset in the fight against cancer.

Collaborations: Some of Xiaoya Ma's notable coworkers include Yonglei Shang and Aude I Segaliny. Their collaborative efforts enhance the research environment and foster innovation within their projects.

Conclusion: Xiaoya Ma's contributions to the field of biomedical engineering, particularly through his patent on anti-CD3 constructs, demonstrate his commitment to advancing cancer treatment. His work continues to inspire and pave the way for future innovations in immunotherapy.